Richard Jonathan Cohen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Cardiovascular | 38 | 2019 | 996 | 2.900 |
Why?
|
| Tachycardia, Ventricular | 21 | 2021 | 1273 | 1.980 |
Why?
|
| Electrocardiography | 51 | 2013 | 6442 | 1.840 |
Why?
|
| Body Surface Potential Mapping | 10 | 2019 | 238 | 1.810 |
Why?
|
| Baroreflex | 10 | 2004 | 146 | 1.690 |
Why?
|
| Arrhythmias, Cardiac | 29 | 2015 | 2268 | 1.660 |
Why?
|
| Heart Rate | 53 | 2013 | 4091 | 1.590 |
Why?
|
| Cardiac Output | 10 | 2019 | 854 | 1.510 |
Why?
|
| Signal Processing, Computer-Assisted | 21 | 2014 | 1534 | 1.400 |
Why?
|
| Vascular Resistance | 9 | 2019 | 936 | 1.380 |
Why?
|
| Heart Conduction System | 21 | 2013 | 1047 | 1.360 |
Why?
|
| Catheter Ablation | 11 | 2022 | 2758 | 1.170 |
Why?
|
| Ventricular Fibrillation | 14 | 2008 | 538 | 1.100 |
Why?
|
| Blood Pressure | 26 | 2019 | 8554 | 0.990 |
Why?
|
| Autonomic Nervous System | 18 | 2005 | 671 | 0.970 |
Why?
|
| Hypotension, Orthostatic | 8 | 2006 | 255 | 0.870 |
Why?
|
| Algorithms | 39 | 2021 | 13881 | 0.840 |
Why?
|
| Death, Sudden, Cardiac | 9 | 2012 | 1541 | 0.760 |
Why?
|
| Bed Rest | 10 | 2005 | 84 | 0.760 |
Why?
|
| Defibrillators, Implantable | 9 | 2015 | 1440 | 0.740 |
Why?
|
| Nonlinear Dynamics | 12 | 2002 | 502 | 0.730 |
Why?
|
| Computer Simulation | 25 | 2013 | 6196 | 0.700 |
Why?
|
| Weightlessness Simulation | 6 | 2006 | 40 | 0.700 |
Why?
|
| Electrocardiography, Ambulatory | 7 | 2008 | 585 | 0.660 |
Why?
|
| Sus scrofa | 1 | 2019 | 437 | 0.610 |
Why?
|
| Sympathetic Nervous System | 8 | 2013 | 514 | 0.580 |
Why?
|
| Blood Pressure Determination | 2 | 2012 | 634 | 0.520 |
Why?
|
| Heart | 13 | 2021 | 4467 | 0.490 |
Why?
|
| Cardiovascular Physiological Phenomena | 9 | 2001 | 235 | 0.480 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2010 | 719 | 0.480 |
Why?
|
| Stroke Volume | 8 | 2019 | 5007 | 0.450 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2013 | 1018 | 0.410 |
Why?
|
| Pressoreceptors | 2 | 2001 | 100 | 0.380 |
Why?
|
| Exercise Test | 8 | 2013 | 2074 | 0.370 |
Why?
|
| Models, Biological | 12 | 2012 | 9583 | 0.370 |
Why?
|
| Electrophysiology | 14 | 1999 | 1308 | 0.370 |
Why?
|
| Swine | 9 | 2022 | 5917 | 0.320 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1423 | 0.310 |
Why?
|
| Weightlessness | 2 | 2005 | 87 | 0.310 |
Why?
|
| Heart Ventricles | 6 | 2012 | 3821 | 0.290 |
Why?
|
| Hemodynamics | 7 | 2013 | 4199 | 0.290 |
Why?
|
| Arrhythmia, Sinus | 2 | 2001 | 56 | 0.290 |
Why?
|
| Hypotension | 1 | 2013 | 884 | 0.290 |
Why?
|
| Cardiac Pacing, Artificial | 6 | 1997 | 845 | 0.280 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2012 | 1366 | 0.280 |
Why?
|
| Respiration | 7 | 2001 | 1653 | 0.280 |
Why?
|
| Ventricular Function | 5 | 2002 | 416 | 0.280 |
Why?
|
| Physiology | 1 | 2006 | 115 | 0.270 |
Why?
|
| Parasympathetic Nervous System | 5 | 2003 | 141 | 0.270 |
Why?
|
| Reproducibility of Results | 14 | 2019 | 19905 | 0.260 |
Why?
|
| Autonomic Nerve Block | 2 | 1997 | 72 | 0.260 |
Why?
|
| Head-Down Tilt | 8 | 2006 | 64 | 0.260 |
Why?
|
| Posture | 8 | 1999 | 958 | 0.260 |
Why?
|
| Aorta | 2 | 2012 | 2061 | 0.260 |
Why?
|
| Syncope | 2 | 2005 | 429 | 0.260 |
Why?
|
| Adaptation, Physiological | 4 | 2006 | 1312 | 0.260 |
Why?
|
| Monitoring, Physiologic | 5 | 2006 | 1738 | 0.240 |
Why?
|
| Least-Squares Analysis | 7 | 2008 | 379 | 0.230 |
Why?
|
| Tilt-Table Test | 5 | 2005 | 78 | 0.230 |
Why?
|
| Blood Circulation | 4 | 2004 | 251 | 0.230 |
Why?
|
| Linear Models | 6 | 1997 | 5952 | 0.230 |
Why?
|
| Sensitivity and Specificity | 11 | 2013 | 14722 | 0.230 |
Why?
|
| Homeostasis | 2 | 2004 | 3340 | 0.220 |
Why?
|
| Midodrine | 2 | 2006 | 22 | 0.220 |
Why?
|
| Catheters | 3 | 2022 | 425 | 0.220 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2013 | 2073 | 0.220 |
Why?
|
| Propranolol | 8 | 2001 | 502 | 0.210 |
Why?
|
| Leg | 3 | 2005 | 1116 | 0.200 |
Why?
|
| Liver Transplantation | 1 | 2013 | 2119 | 0.200 |
Why?
|
| Space Simulation | 1 | 2001 | 10 | 0.200 |
Why?
|
| Models, Anatomic | 2 | 2008 | 691 | 0.200 |
Why?
|
| Atropine | 6 | 2001 | 244 | 0.200 |
Why?
|
| Lung Volume Measurements | 7 | 1999 | 378 | 0.190 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2001 | 177 | 0.190 |
Why?
|
| Humans | 102 | 2022 | 744343 | 0.180 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 4 | 2012 | 493 | 0.180 |
Why?
|
| Data Interpretation, Statistical | 2 | 2008 | 2716 | 0.180 |
Why?
|
| Risk Assessment | 10 | 2012 | 23338 | 0.180 |
Why?
|
| Animals | 38 | 2022 | 168757 | 0.170 |
Why?
|
| Models, Statistical | 5 | 2006 | 5102 | 0.170 |
Why?
|
| Myocardial Infarction | 5 | 2003 | 11727 | 0.170 |
Why?
|
| Torsades de Pointes | 1 | 2000 | 78 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2003 | 851 | 0.170 |
Why?
|
| Cardiovascular System | 5 | 2004 | 832 | 0.170 |
Why?
|
| Supine Position | 5 | 2001 | 205 | 0.170 |
Why?
|
| Dogs | 12 | 1997 | 3912 | 0.170 |
Why?
|
| Motion Sickness | 1 | 1998 | 35 | 0.150 |
Why?
|
| Tachycardia | 2 | 1998 | 619 | 0.150 |
Why?
|
| Parasympatholytics | 1 | 1997 | 91 | 0.150 |
Why?
|
| Liver | 1 | 2013 | 7474 | 0.150 |
Why?
|
| Scopolamine | 1 | 1997 | 99 | 0.150 |
Why?
|
| Ventricular Premature Complexes | 1 | 1997 | 111 | 0.140 |
Why?
|
| Normal Distribution | 2 | 2008 | 280 | 0.140 |
Why?
|
| Muscarinic Antagonists | 1 | 1997 | 137 | 0.140 |
Why?
|
| Models, Animal | 2 | 2001 | 2171 | 0.140 |
Why?
|
| Atrial Function, Right | 3 | 2004 | 33 | 0.140 |
Why?
|
| Biophysics | 1 | 1997 | 383 | 0.130 |
Why?
|
| Cell Physiological Phenomena | 1 | 1997 | 154 | 0.130 |
Why?
|
| Male | 52 | 2015 | 350118 | 0.130 |
Why?
|
| Cardiovascular Deconditioning | 2 | 2005 | 9 | 0.130 |
Why?
|
| Sheep | 3 | 2004 | 1437 | 0.130 |
Why?
|
| Predictive Value of Tests | 10 | 2008 | 15076 | 0.130 |
Why?
|
| Prealbumin | 1 | 2016 | 210 | 0.130 |
Why?
|
| Death, Sudden | 1 | 1996 | 302 | 0.120 |
Why?
|
| Neuromuscular Junction | 1 | 1997 | 398 | 0.120 |
Why?
|
| Bioelectric Energy Sources | 1 | 2014 | 17 | 0.120 |
Why?
|
| Sudden Infant Death | 2 | 1987 | 291 | 0.120 |
Why?
|
| Adult | 41 | 2015 | 214055 | 0.120 |
Why?
|
| Heart Failure | 5 | 2012 | 10900 | 0.120 |
Why?
|
| Endocrine System | 2 | 2005 | 113 | 0.120 |
Why?
|
| Purkinje Fibers | 1 | 1993 | 32 | 0.110 |
Why?
|
| Equipment Design | 3 | 2022 | 3582 | 0.110 |
Why?
|
| Feedback | 2 | 1997 | 795 | 0.110 |
Why?
|
| Atrioventricular Node | 1 | 1994 | 182 | 0.110 |
Why?
|
| Kinetics | 6 | 2016 | 6473 | 0.110 |
Why?
|
| Bundle of His | 1 | 1993 | 87 | 0.110 |
Why?
|
| Phantoms, Imaging | 2 | 2013 | 2480 | 0.110 |
Why?
|
| Models, Neurological | 2 | 2003 | 1774 | 0.110 |
Why?
|
| Body Surface Area | 1 | 1992 | 198 | 0.110 |
Why?
|
| Plaque, Amyloid | 1 | 2016 | 729 | 0.100 |
Why?
|
| Electric Countershock | 1 | 2015 | 534 | 0.100 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 1997 | 188 | 0.100 |
Why?
|
| Protein Denaturation | 1 | 2012 | 237 | 0.100 |
Why?
|
| Metal Nanoparticles | 1 | 2016 | 405 | 0.100 |
Why?
|
| Genes, MHC Class I | 1 | 2012 | 258 | 0.100 |
Why?
|
| Gadolinium | 1 | 2016 | 952 | 0.100 |
Why?
|
| Electric Impedance | 1 | 1995 | 729 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 459 | 0.100 |
Why?
|
| Pressure | 2 | 2004 | 1203 | 0.100 |
Why?
|
| Heart Transplantation | 3 | 1996 | 3110 | 0.100 |
Why?
|
| Bundle-Branch Block | 1 | 1992 | 270 | 0.100 |
Why?
|
| Ovalbumin | 1 | 2012 | 719 | 0.090 |
Why?
|
| Renin | 4 | 2005 | 642 | 0.090 |
Why?
|
| Atrial Function | 3 | 2000 | 107 | 0.080 |
Why?
|
| Female | 34 | 2016 | 380194 | 0.080 |
Why?
|
| Regression Analysis | 4 | 2006 | 6459 | 0.080 |
Why?
|
| Mathematics | 4 | 1997 | 728 | 0.080 |
Why?
|
| Plethysmography | 2 | 2005 | 180 | 0.080 |
Why?
|
| Protein Folding | 1 | 2012 | 843 | 0.080 |
Why?
|
| Reflex | 1 | 1990 | 365 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3508 | 0.080 |
Why?
|
| Stochastic Processes | 4 | 2003 | 344 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2008 | 2971 | 0.080 |
Why?
|
| Middle Aged | 24 | 2015 | 213383 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 3 | 2000 | 1681 | 0.080 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2001 | 257 | 0.080 |
Why?
|
| Endocytosis | 1 | 2012 | 985 | 0.070 |
Why?
|
| Coronary Disease | 6 | 1997 | 6077 | 0.070 |
Why?
|
| Feasibility Studies | 4 | 2003 | 5078 | 0.070 |
Why?
|
| Endocardium | 1 | 1988 | 263 | 0.070 |
Why?
|
| Immobilization | 2 | 2006 | 236 | 0.070 |
Why?
|
| Ligands | 3 | 2012 | 3282 | 0.070 |
Why?
|
| Spectrum Analysis | 3 | 1997 | 454 | 0.070 |
Why?
|
| Myocardial Contraction | 3 | 2003 | 1585 | 0.070 |
Why?
|
| Disease-Free Survival | 4 | 2015 | 6895 | 0.070 |
Why?
|
| Aerospace Medicine | 1 | 2006 | 84 | 0.070 |
Why?
|
| Reference Values | 5 | 2001 | 4982 | 0.070 |
Why?
|
| Fourier Analysis | 4 | 1993 | 447 | 0.070 |
Why?
|
| Disease Susceptibility | 4 | 2004 | 1782 | 0.060 |
Why?
|
| Muscles | 1 | 1990 | 1614 | 0.060 |
Why?
|
| Exercise | 3 | 1997 | 5615 | 0.060 |
Why?
|
| Peptides | 2 | 2016 | 4409 | 0.060 |
Why?
|
| Heart Diseases | 1 | 1997 | 2788 | 0.060 |
Why?
|
| Protein Binding | 2 | 2016 | 9386 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 1996 | 1912 | 0.060 |
Why?
|
| Hippocampus | 1 | 2016 | 3675 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5097 | 0.060 |
Why?
|
| Atrial Flutter | 1 | 2006 | 263 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 3587 | 0.060 |
Why?
|
| Heart Arrest | 2 | 2003 | 1470 | 0.060 |
Why?
|
| Space Flight | 1 | 2005 | 188 | 0.060 |
Why?
|
| Pericardium | 1 | 1988 | 667 | 0.060 |
Why?
|
| Principal Component Analysis | 1 | 2006 | 940 | 0.060 |
Why?
|
| Binding Sites | 1 | 2012 | 6114 | 0.060 |
Why?
|
| Haptens | 2 | 1993 | 166 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2006 | 642 | 0.050 |
Why?
|
| Myocardium | 4 | 2003 | 4776 | 0.050 |
Why?
|
| Steam | 1 | 2022 | 31 | 0.050 |
Why?
|
| Prognosis | 6 | 2012 | 29063 | 0.050 |
Why?
|
| Aged | 16 | 2015 | 163280 | 0.050 |
Why?
|
| Aldosterone | 2 | 2005 | 877 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2012 | 3748 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 1525 | 0.050 |
Why?
|
| Observer Variation | 1 | 2008 | 2593 | 0.050 |
Why?
|
| Follow-Up Studies | 6 | 2015 | 39050 | 0.050 |
Why?
|
| Action Potentials | 4 | 2003 | 1806 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2008 | 1167 | 0.050 |
Why?
|
| Electrodes | 2 | 2014 | 619 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2022 | 301 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2001 | 332 | 0.050 |
Why?
|
| Kidney | 3 | 2005 | 7186 | 0.050 |
Why?
|
| Carotid Sinus | 1 | 2000 | 45 | 0.050 |
Why?
|
| Quality Control | 1 | 2003 | 841 | 0.050 |
Why?
|
| Catheterization | 1 | 2006 | 1470 | 0.050 |
Why?
|
| Lung | 4 | 2000 | 9856 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2002 | 578 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2003 | 767 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 2004 | 1826 | 0.040 |
Why?
|
| Hemorrhage | 1 | 1991 | 3461 | 0.040 |
Why?
|
| Sodium | 4 | 2005 | 1623 | 0.040 |
Why?
|
| Time Factors | 10 | 2013 | 40075 | 0.040 |
Why?
|
| Papillary Muscles | 1 | 1999 | 203 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 1985 | 1572 | 0.040 |
Why?
|
| Reference Standards | 1 | 2002 | 1025 | 0.040 |
Why?
|
| Antigens | 2 | 1995 | 1466 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2015 | 53288 | 0.040 |
Why?
|
| Melatonin | 1 | 2003 | 721 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 1998 | 330 | 0.040 |
Why?
|
| Biomedical Engineering | 1 | 1999 | 296 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 832 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2002 | 1254 | 0.040 |
Why?
|
| Risk Factors | 6 | 2008 | 72290 | 0.040 |
Why?
|
| Glycopyrrolate | 2 | 1991 | 33 | 0.040 |
Why?
|
| Hypothermia, Induced | 3 | 1988 | 752 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2001 | 789 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 1988 | 2148 | 0.040 |
Why?
|
| Tetralogy of Fallot | 1 | 2002 | 623 | 0.040 |
Why?
|
| Recurrence | 2 | 1998 | 8340 | 0.040 |
Why?
|
| Thorax | 1 | 2000 | 547 | 0.040 |
Why?
|
| Vena Cava, Inferior | 1 | 2000 | 440 | 0.040 |
Why?
|
| Vagus Nerve | 2 | 1989 | 438 | 0.030 |
Why?
|
| Nitroprusside | 2 | 1990 | 275 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1997 | 327 | 0.030 |
Why?
|
| Rotation | 1 | 1998 | 523 | 0.030 |
Why?
|
| Potassium | 3 | 2005 | 1336 | 0.030 |
Why?
|
| Long QT Syndrome | 1 | 2000 | 453 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2016 | 274 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8037 | 0.030 |
Why?
|
| Diabetic Neuropathies | 1 | 1999 | 400 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1997 | 711 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2003 | 2967 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1995 | 1369 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2003 | 1637 | 0.030 |
Why?
|
| Anisotropy | 1 | 1998 | 1265 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 10180 | 0.030 |
Why?
|
| Actuarial Analysis | 1 | 1994 | 378 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1997 | 1137 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 1989 | 1767 | 0.030 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1993 | 64 | 0.030 |
Why?
|
| Oligopeptides | 2 | 1994 | 1189 | 0.030 |
Why?
|
| Plethysmography, Impedance | 1 | 1993 | 43 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1995 | 527 | 0.030 |
Why?
|
| Dinitrophenols | 1 | 1992 | 57 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1993 | 363 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 315 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2624 | 0.030 |
Why?
|
| Heart Atria | 1 | 1997 | 1357 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1996 | 1842 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1991 | 411 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1991 | 246 | 0.020 |
Why?
|
| Nerve Block | 1 | 1997 | 644 | 0.020 |
Why?
|
| Mice | 3 | 2016 | 81183 | 0.020 |
Why?
|
| Renin-Angiotensin System | 2 | 2005 | 759 | 0.020 |
Why?
|
| Veins | 2 | 2004 | 770 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 7913 | 0.020 |
Why?
|
| Periodicity | 1 | 1991 | 363 | 0.020 |
Why?
|
| Forecasting | 1 | 1998 | 2951 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1990 | 301 | 0.020 |
Why?
|
| Oscillometry | 1 | 1989 | 147 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1995 | 2540 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1995 | 1821 | 0.020 |
Why?
|
| Adolescent | 6 | 2002 | 85781 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 18029 | 0.020 |
Why?
|
| Artifacts | 1 | 1996 | 1904 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1990 | 909 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1996 | 1265 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1991 | 1959 | 0.020 |
Why?
|
| Reaction Time | 1 | 1993 | 2097 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2003 | 2726 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1998 | 10252 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 1993 | 9274 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12788 | 0.020 |
Why?
|
| Endocrine Glands | 1 | 2004 | 103 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2000 | 12245 | 0.010 |
Why?
|
| Antibodies | 1 | 1992 | 2460 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9734 | 0.010 |
Why?
|
| Vasomotor System | 1 | 2004 | 209 | 0.010 |
Why?
|
| Tropomyosin | 1 | 2003 | 102 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2003 | 40561 | 0.010 |
Why?
|
| Survivors | 1 | 1994 | 2291 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7799 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2006 | 12026 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1993 | 5974 | 0.010 |
Why?
|
| Teprotide | 1 | 1981 | 28 | 0.010 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2004 | 281 | 0.010 |
Why?
|
| Risk | 1 | 1994 | 9687 | 0.010 |
Why?
|
| Differential Threshold | 1 | 2001 | 80 | 0.010 |
Why?
|
| Clone Cells | 2 | 1995 | 1692 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6538 | 0.010 |
Why?
|
| Methods | 1 | 1981 | 1129 | 0.010 |
Why?
|
| Angiotensins | 1 | 1981 | 151 | 0.010 |
Why?
|
| Sarcomeres | 1 | 2003 | 374 | 0.010 |
Why?
|
| Software | 1 | 1995 | 4443 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2003 | 8301 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1994 | 4479 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 57776 | 0.010 |
Why?
|
| Troponin I | 1 | 2003 | 619 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1999 | 198 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 1999 | 219 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1999 | 554 | 0.010 |
Why?
|
| Computers | 1 | 1981 | 612 | 0.010 |
Why?
|
| Cardiology | 1 | 1989 | 1668 | 0.010 |
Why?
|
| Biopsy | 1 | 1989 | 6756 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1988 | 9146 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4568 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1678 | 0.010 |
Why?
|
| Actins | 1 | 2003 | 2121 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1989 | 4397 | 0.010 |
Why?
|
| Infant | 2 | 1987 | 35136 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 24260 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2689 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 6365 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2005 | 2925 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2013 | 63114 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 5882 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 13815 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 936 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1993 | 370 | 0.010 |
Why?
|
| Solubility | 1 | 1994 | 1085 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10397 | 0.010 |
Why?
|
| Polymers | 1 | 1999 | 1621 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 18111 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.010 |
Why?
|
| Pyridinium Compounds | 1 | 1991 | 84 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1994 | 973 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1981 | 3798 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1998 | 77449 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1991 | 1386 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.010 |
Why?
|
| Epitopes | 1 | 1995 | 2571 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1992 | 694 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1991 | 675 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12354 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1991 | 1917 | 0.000 |
Why?
|
| Aging | 1 | 1999 | 8664 | 0.000 |
Why?
|
| Child | 1 | 2001 | 77709 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1990 | 8949 | 0.000 |
Why?
|